Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on ionic liquid catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102391060B details a green acetylation method using [HDBU]OAc. High yields, solvent-free conditions offer significant supply chain advantages for pharma intermediates.
Patent CN103880728A reveals a solvent-free, room-temperature method for producing high-purity diindolylmethane compounds using reusable acidic ionic liquids, offering significant cost and environmental advantages.
Patent CN108250049A reveals magnetic ionic liquid catalyst for bisphenol fluorene. Offers high purity, mild conditions, and supply chain stability for polymer manufacturers seeking reliable intermediates.
Novel ionic liquid catalysis for 4H-benzo[b]pyran derivatives ensures high purity and cost-effective manufacturing for pharmaceutical intermediates globally.
Patent CN107162932B reveals a one-step benzonitrile synthesis using ionic liquids. Achieve high purity, reduced corrosion, and scalable manufacturing for pharmaceutical intermediates.
Patent CN112142750A reveals a green one-pot synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and scalable production capabilities.
Patent CN101157650B details an ionic liquid-catalyzed route using dimethyl carbonate, offering high purity and safety for pharmaceutical intermediates.
Patent CN108358880A reveals ionic liquid catalysis for high-purity 4H-benzo[b]pyran compounds. Achieve cost reduction in pharmaceutical intermediates manufacturing with solvent-free technology.
Patent CN102633625B reveals green ionic liquid method for high-purity fluorocinnamic acid. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN103145630A details a green synthesis method for quinoxalines using water and recyclable ionic liquids, offering significant cost and environmental advantages for pharmaceutical intermediates.
Patent CN110655494A details a novel ionic liquid-catalyzed route for triazinone. Achieves 92.4% yield with reduced waste, offering cost-effective agrochemical intermediate manufacturing.
Novel catalytic route for Vitamin K3 intermediate. High efficiency, safe, scalable. Reliable supplier for pharma intermediates.
Patent CN102766081A reveals a green, solvent-free route for bis-indolylmethane derivatives using reusable ionic liquids, offering significant cost and supply chain advantages.
Patent CN108047009B reveals a high-yield carbonylation method using recyclable ionic liquids, offering significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110372611A reveals green solvent-free synthesis using heteropolyacid ionic liquids for high-purity quinazolinone intermediates ensuring cost reduction and supply reliability.
Patent CN102250052A details a continuous ionic liquid catalyzed process for high-purity cyclic carbonates, offering significant cost reduction and supply chain reliability for battery electrolyte manufacturing.
Patent CN109734646B details a high-yield method for diether diphthalimide using ionic liquids, offering significant cost reduction and purity benefits for PEI monomer manufacturing.
Novel acidic ionic liquid catalyst method ensures high purity and recyclable system for pharmaceutical intermediate manufacturing supply chain efficiency.
Patent CN102267893B details a high-yield Royal Jelly Acid synthesis using recyclable SiO2-Tempo and ionic liquids, offering significant cost and supply chain advantages.
Patent CN103360225B details a green Fries rearrangement method. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.